The typical plan for an every-other-week dosing strategy may involve: Keeping the same dose strength (for example, 1.0 mg or 2.4 mg) Injecting the medication every 14 days instead of weekly Using this schedule primarily during the maintenance phase, but not during active weight loss The risks of biweekly dosing Biweekly dosing schedules may have potential risks
Education and Counselling for People Considering a GLP-1 RA People with T2D who are considering a GLP-1 RA should be adequately informed about the mode of action and expected benefits, including HbA 1c and weight reductions, and if appropriate, reduced CV risk associated with GLP-1 RAs
Understanding your genetic predispositions in peptide pathways can support a more informed conversation with your provider about transition timing, expected response patterns, and monitoring focus
It helps increase NAD+ levels , supporting cellular repair, metabolism, and overall vitality
doi: 10.1161/CIRCRESAHA.116.306374 184 ShonoT.OnoM.IzumiH.JimiS